World Health Assembly Topic: Pandemic Flu Financing, Virus Sharing, Extension 17/05/2017 Catherine Saez There are many who see the World Health Organization mechanism to prepare and face the next influenza pandemic and insure availability of treatments as a success. However, some questions remain. Continue reading -> IP-Watch Guide To 2017 World Health Assembly: Election, Budget, Antibiotics, Cancer, R&D And More 16/05/2017 Catherine Saez In a few days, the 70th World Health Assembly will open its doors in Geneva with a marathon agenda, and over 4,000 registered delegates. The election of a new director general, the approval of the budget for the next biennium (2018/2019) are set to capture the attention of member states. However, many other subjects require their consideration, such as a resolution on cancer treatment costs, research and development for epidemic diseases, for new antibiotics, for medicines affecting primarily poor populations, access to medicines, and the influenza pandemic preparedness framework. Continue reading -> Longest, Biggest World Health Assembly Ever Set To Open With Election, Budget Topping Agenda 12/05/2017 Catherine Saez The 70th World Health Assembly opening in a few days is the WHA of superlatives, according to a World Health Organization’s official. It is the longest assembly ever, with nine days of meeting, the largest number delegates, of agenda items, and of documents. It is also when the new WHO new director general will be elected, and when the WHO next budget is expected to be approved. Continue reading -> WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> WHO Touts Its Past Work On Improving Access To Medicines 11/05/2017 Elise De Geyter The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan. Continue reading -> Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? 10/05/2017 Tatum Anderson The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
IP-Watch Guide To 2017 World Health Assembly: Election, Budget, Antibiotics, Cancer, R&D And More 16/05/2017 Catherine Saez In a few days, the 70th World Health Assembly will open its doors in Geneva with a marathon agenda, and over 4,000 registered delegates. The election of a new director general, the approval of the budget for the next biennium (2018/2019) are set to capture the attention of member states. However, many other subjects require their consideration, such as a resolution on cancer treatment costs, research and development for epidemic diseases, for new antibiotics, for medicines affecting primarily poor populations, access to medicines, and the influenza pandemic preparedness framework. Continue reading -> Longest, Biggest World Health Assembly Ever Set To Open With Election, Budget Topping Agenda 12/05/2017 Catherine Saez The 70th World Health Assembly opening in a few days is the WHA of superlatives, according to a World Health Organization’s official. It is the longest assembly ever, with nine days of meeting, the largest number delegates, of agenda items, and of documents. It is also when the new WHO new director general will be elected, and when the WHO next budget is expected to be approved. Continue reading -> WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> WHO Touts Its Past Work On Improving Access To Medicines 11/05/2017 Elise De Geyter The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan. Continue reading -> Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? 10/05/2017 Tatum Anderson The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Longest, Biggest World Health Assembly Ever Set To Open With Election, Budget Topping Agenda 12/05/2017 Catherine Saez The 70th World Health Assembly opening in a few days is the WHA of superlatives, according to a World Health Organization’s official. It is the longest assembly ever, with nine days of meeting, the largest number delegates, of agenda items, and of documents. It is also when the new WHO new director general will be elected, and when the WHO next budget is expected to be approved. Continue reading -> WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> WHO Touts Its Past Work On Improving Access To Medicines 11/05/2017 Elise De Geyter The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan. Continue reading -> Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? 10/05/2017 Tatum Anderson The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines 12/05/2017 Catherine Saez The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants. Continue reading -> WHO Touts Its Past Work On Improving Access To Medicines 11/05/2017 Elise De Geyter The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan. Continue reading -> Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? 10/05/2017 Tatum Anderson The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Touts Its Past Work On Improving Access To Medicines 11/05/2017 Elise De Geyter The World Health Organization today published an item entitled, Access to medicines: making market forces serve the poor, a chapter from its report ‘Ten years in public health 2007-2017’ of outgoing WHO Director General Margaret Chan. Continue reading -> Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? 10/05/2017 Tatum Anderson The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Shortage Of Affordable Insulin: Should WHO Extend Prequalification To Biosimilars? 10/05/2017 Tatum Anderson The WHO last week announced plans to explore options for prequalifying insulin, a process that already assesses the quality, safety and efficacy of medicinal products, such as tuberculosis and malaria drugs. The WHO is considering whether to extend the prequalification process to manufacturers creating me-too versions of insulins, more commonly known as biosimilars. Continue reading -> US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US, EU Diverge On Medical Diagnostic Patents 10/05/2017 Kim Treanor A recent article in the journal Nature Biotechnology finds that since a key United States Supreme Court decision, the European Union and United States have diverged in their patent filings for medical diagnostics. Continue reading -> MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
MSF Warns Of Threats To Public Health In Asian Trade Agreement IP Proposals 09/05/2017 Elise De Geyter The 18th round of the Regional Comprehensive Economic Partnership (RCEP) trade agreement negotiations is taking place this week in Manila, Philippines. Health activists warn that Japan and South Korea are pushing for measures that go beyond international trade rules on intellectual property, including extending patent terms and data exclusivity in countries such as India, a primary source of cheaper generic medicines. Continue reading -> The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The True Believer: An Interview With New IFPMA Director General Thomas Cueni 08/05/2017 Catherine Saez The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy. Continue reading -> Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Plain Packaging For Tobacco Products: WTO Dispute Settlement Body Allegedly Backs Australia 05/05/2017 Catherine Saez According to many media this morning, citing anonymous sources, the World Trade Organization Dispute Settlement Body has reached a decision in a dispute challenging Australia's tobacco product plain packaging law. Australia appears to have won the case. The WTO is non-committal and says only a "confidential interim report" has been circulated. Australia is not commenting. Continue reading -> Posts navigation Older postsNewer posts